Actively Recruiting
COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Led by University Hospital, Akershus · Updated on 2022-02-16
350
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University Hospital, Akershus
Lead Sponsor
S
St. Olavs Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research investigates COVID-19 infection in children aged 0 to 18 years who are hospitalized in Norway. It aims to study three key areas: factors that increase the risk of severe illness, the body's immune response during infection, and the long-term effects, including persistent fatigue after infection. The study is designed as a nationwide, prospective cohort to better understand how the disease affects children. Children admitted with suspected COVID-19 are enrolled and grouped based on whether they test positive or negative for the virus. Those confirmed positive form the case group, while those negative serve as controls. Both groups are followed for six months to assess outcomes and immune responses. The study includes three focused work areas: risk factors for severe illness, immunological mechanisms during acute infection, and the prevalence and risks of long-lasting complications. Participants will undergo monitoring and assessments over six months to track their health outcomes, immune reactions, and any chronic symptoms that may develop. Researchers will collect clinical data and evaluate the natural history of the infection, including genetic and inflammatory factors. The primary outcomes measured are risk factors for severe infection, immunological responses, and long-term health consequences related to COVID-19 in hospitalized children.
CONDITIONS
Brief Title
COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspected COVID-19 infection
- Age between 0 and 18 years
- Hospitalized with suspected COVID-19
You will not qualify if you...
- Age over 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants who are hospitalized with suspected COVID-19 are observed to investigate risk factors, immune response, and long-term outcomes.
Visits scheduled periodically during hospitalization and follow-up assessments over 6 months
Trial Site Locations
Total: 1 location
1
Akershus universistetssykehus
Lørenskog, Norway
Actively Recruiting
Research Team
C
Christopher Inchley, Phd
L
Lise Beier Havdal
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here